Please select the option that best describes you:

How would you treat patient with a stage IV lung adenocarcinoma, an exon 21 p.H835L mutation, high TMB, and negative PD-L1?  

What would be the role of an EGFR TKI?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more